FR2171907B2 - - Google Patents

Info

Publication number
FR2171907B2
FR2171907B2 FR7205016A FR7205016A FR2171907B2 FR 2171907 B2 FR2171907 B2 FR 2171907B2 FR 7205016 A FR7205016 A FR 7205016A FR 7205016 A FR7205016 A FR 7205016A FR 2171907 B2 FR2171907 B2 FR 2171907B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7205016A
Other languages
French (fr)
Other versions
FR2171907A2 (US06248540-20010619-C00021.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE795417D priority Critical patent/BE795417A/xx
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7205016A priority patent/FR2171907B2/fr
Priority to US00330403A priority patent/US3855197A/en
Priority to DE2307051A priority patent/DE2307051C3/de
Priority to HURO704A priority patent/HU168849B/hu
Priority to SE7302080A priority patent/SE425833B/xx
Priority to ES411602A priority patent/ES411602A2/es
Priority to CA163,703A priority patent/CA993389A/fr
Priority to JP48017544A priority patent/JPS4896792A/ja
Priority to GB753073A priority patent/GB1412202A/en
Priority to NLAANVRAGE7302132,A priority patent/NL174267C/xx
Priority to CH221773A priority patent/CH564084A5/xx
Priority to DK80873A priority patent/DK146724C/da
Publication of FR2171907A2 publication Critical patent/FR2171907A2/fr
Priority to US508335A priority patent/US3929994A/en
Application granted granted Critical
Publication of FR2171907B2 publication Critical patent/FR2171907B2/fr
Priority to JP59034485A priority patent/JPS6028813B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26Klebsiella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7205016A 1969-05-20 1972-02-15 Expired FR2171907B2 (US06248540-20010619-C00021.png)

Priority Applications (15)

Application Number Priority Date Filing Date Title
BE795417D BE795417A (fr) 1972-02-15 Nouveaux composes d'origine-bacterienne et procede d'obtention
FR7205016A FR2171907B2 (US06248540-20010619-C00021.png) 1972-02-15 1972-02-15
US00330403A US3855197A (en) 1969-05-20 1973-02-07 Glycoproteins extracted from microorganisms
HURO704A HU168849B (US06248540-20010619-C00021.png) 1972-02-15 1973-02-13
DE2307051A DE2307051C3 (de) 1972-02-15 1973-02-13 Verfahren zum Reinigen von langsamen a - und ß -Glykoproteinen aus Mikrobenkörpern und diese enthaltende pharmazeutische Zusammensetzungen
JP48017544A JPS4896792A (US06248540-20010619-C00021.png) 1972-02-15 1973-02-14
ES411602A ES411602A2 (es) 1972-02-15 1973-02-14 Un procedimiento de preparacion de alfa y beta-glicopro- teinas lentas.
CA163,703A CA993389A (fr) 1972-02-15 1973-02-14 Procede d'obtention d'.alpha. et .beta. glycoproteines lentes
SE7302080A SE425833B (sv) 1972-02-15 1973-02-14 Sett att rena en blanding av alfa- och beta-glykoproteiner
GB753073A GB1412202A (en) 1972-02-15 1973-02-15 Purification of glycoproteins
NLAANVRAGE7302132,A NL174267C (nl) 1972-02-15 1973-02-15 Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
CH221773A CH564084A5 (US06248540-20010619-C00021.png) 1972-02-15 1973-02-15
DK80873A DK146724C (da) 1972-02-15 1973-02-15 Fremgangsmaade til fremstilling af langsomme alfa- og beta-glycoproteiner
US508335A US3929994A (en) 1969-05-20 1974-09-23 Anti-inflammatory glycoprotein compositions and method of use
JP59034485A JPS6028813B2 (ja) 1972-02-15 1984-02-27 遅行性アルフア及びベ−タ糖たん白質を得る方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7205016A FR2171907B2 (US06248540-20010619-C00021.png) 1972-02-15 1972-02-15

Publications (2)

Publication Number Publication Date
FR2171907A2 FR2171907A2 (US06248540-20010619-C00021.png) 1973-09-28
FR2171907B2 true FR2171907B2 (US06248540-20010619-C00021.png) 1975-04-25

Family

ID=9093508

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7205016A Expired FR2171907B2 (US06248540-20010619-C00021.png) 1969-05-20 1972-02-15

Country Status (12)

Country Link
JP (2) JPS4896792A (US06248540-20010619-C00021.png)
BE (1) BE795417A (US06248540-20010619-C00021.png)
CA (1) CA993389A (US06248540-20010619-C00021.png)
CH (1) CH564084A5 (US06248540-20010619-C00021.png)
DE (1) DE2307051C3 (US06248540-20010619-C00021.png)
DK (1) DK146724C (US06248540-20010619-C00021.png)
ES (1) ES411602A2 (US06248540-20010619-C00021.png)
FR (1) FR2171907B2 (US06248540-20010619-C00021.png)
GB (1) GB1412202A (US06248540-20010619-C00021.png)
HU (1) HU168849B (US06248540-20010619-C00021.png)
NL (1) NL174267C (US06248540-20010619-C00021.png)
SE (1) SE425833B (US06248540-20010619-C00021.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507498A (ja) * 2008-10-31 2012-03-29 エティエン マリー−クリスティーヌ 感染症の治療用の薬剤

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
IT1199301B (it) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012507498A (ja) * 2008-10-31 2012-03-29 エティエン マリー−クリスティーヌ 感染症の治療用の薬剤

Also Published As

Publication number Publication date
JPS59219236A (ja) 1984-12-10
JPS4896792A (US06248540-20010619-C00021.png) 1973-12-10
NL7302132A (US06248540-20010619-C00021.png) 1973-08-17
DE2307051A1 (de) 1973-08-23
ES411602A2 (es) 1976-03-01
CA993389A (fr) 1976-07-20
DK146724C (da) 1984-05-28
SE425833B (sv) 1982-11-15
JPS6028813B2 (ja) 1985-07-06
CH564084A5 (US06248540-20010619-C00021.png) 1975-07-15
NL174267C (nl) 1984-05-16
DE2307051B2 (de) 1979-10-04
FR2171907A2 (US06248540-20010619-C00021.png) 1973-09-28
BE795417A (fr) 1973-08-14
GB1412202A (en) 1975-10-29
DK146724B (da) 1983-12-12
HU168849B (US06248540-20010619-C00021.png) 1976-07-28
DE2307051C3 (de) 1980-06-19

Similar Documents

Publication Publication Date Title
JPS5617704B2 (US06248540-20010619-C00021.png)
FR2171907B2 (US06248540-20010619-C00021.png)
JPS5335099B2 (US06248540-20010619-C00021.png)
JPS494918A (US06248540-20010619-C00021.png)
JPS4959459A (US06248540-20010619-C00021.png)
JPS5422517B2 (US06248540-20010619-C00021.png)
JPS4923775A (US06248540-20010619-C00021.png)
JPS4919223U (US06248540-20010619-C00021.png)
FR2199517A1 (US06248540-20010619-C00021.png)
JPS5215356B2 (US06248540-20010619-C00021.png)
JPS521046B2 (US06248540-20010619-C00021.png)
JPS5531504B2 (US06248540-20010619-C00021.png)
JPS492202U (US06248540-20010619-C00021.png)
AU62006S (US06248540-20010619-C00021.png)
FR2202329A1 (US06248540-20010619-C00021.png)
HU166944B (US06248540-20010619-C00021.png)
CH569679A5 (US06248540-20010619-C00021.png)
CH560331A5 (US06248540-20010619-C00021.png)
CH569471A5 (US06248540-20010619-C00021.png)
CH569331A5 (US06248540-20010619-C00021.png)
CH560841A5 (US06248540-20010619-C00021.png)
CH569688A5 (US06248540-20010619-C00021.png)
CH569913A5 (US06248540-20010619-C00021.png)
CH567359A5 (US06248540-20010619-C00021.png)
CH582141A5 (US06248540-20010619-C00021.png)